MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Drug-induced Parkinsonism and nonmotor symptoms: a case of gustatory rhinorrhea

    S. Casanova, A. Cabral, M. Branco (Vila Nova Gaia, Portugal)

    Objective: We aim to emphasize the relevance of contemplating nonmotor symptoms as possible features of drug-induced parkinsonism, and the utmost importance of further investigation in…
  • 2023 International Congress

    Investigate the association of MAPT haplotype and neuroanatomical structure and its influence on the risk of Parkinson’s disease

    E. Yu, C. Tremblay, A. Vo, Y. Sosero, Z. Gan-Or, A. Dagher, L. Liu ()

    Objective: To investigate if the vulnerability of Parkinson’s Disease (PD) can be reflected in the neuroanatomical structure in different MAPT haplotype carriers. Background: It has…
  • 2023 International Congress

    Bowel symptoms and management practices in Parkinson’s disease and related conditions: results from the PRIME-UK study.

    C. Thomas, E. Tenison, K. Lloyd, M. Smith, Y. Ben-Shlomo, E. Henderson (Gloucestershire, United Kingdom)

    Objective: To describe bowel symptoms and constipation management practices in a large, representative cross-sectional study of Parkinson’s and related disorders. Background: Bowel symptoms, particularly constipation,…
  • 2023 International Congress

    A digital differential diagnostic aid for Parkinson’s disease and other tremor disorders

    C. Papasavvas, D. Bramwell, R. Zietsma, A. Deutschlander, R. Walker (Edinburgh, United Kingdom)

    Objective: To validate an AI-enhanced decision support tool to assist health care professionals (HCP) in distinguishing between patients with Parkinson’s disease (PD) and those with…
  • 2023 International Congress

    Characterization of gait variability of early Parkinson’s disease and multiple system atrophy

    M. Jecmenica Lukic, A. Tomic, I. Stankovic, V. Markovic, N. Kresojevic, N. Dragasevic, M. Svetel, I. Petrovic, S. Radovanovic, V. Kostic (Belgrade, Serbia)

    Objective: to determine the potential differences in gait characteristics between PD-GBA carriers and non-carriers (idiopathic Parkinson’s disease (iPD)), both mutually and in relation to MSA-P.…
  • 2023 International Congress

    Internal tremor in Parkinson disease and essential tremor: a new glance at a common symptom

    A. Fonseca, M. Lima, C. Duque, V. Carvalho, M. Calejo (Matosinhos, Portugal)

    Objective: To assess the prevalence of internal tremor in a cohort of PD versus ET patients and its association with non-motor symptoms. Background: Internal tremor…
  • 2023 International Congress

    PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)

    J. Purks, L. Arbatti, A. Hosamath, A. Amara, K. Anderson, L. Chahine, S. Eberly, D. Kinel, S. Mantri, S. Mathur, D. Oakes, D. Standaert, D. Weintraub, I. Shoulson, C. Marras (Rochester, USA)

    Objective: Describe the relative frequency of bothersome cognitive symptoms reported verbatim by people with PD in the Fox Insight online study. Background: Cognitive decline is…
  • 2023 International Congress

    Caveats regarding a family with PD and LRRK2 mutations

    P. Ferreira, A. Ferreira, D. Fitas, S. Moreira, M. Calejo (Senhora da Hora, Portugal)

    Objective: To describe and discuss genetic considerations regarding a kindred with PD cases with similar clinical characteristics, some with identified mutations in the LRRK2 gene…
  • 2023 International Congress

    Identification of atlastin genetic modifiers in a Hereditary Spastic Paraplegia model in Drosophila

    P. Olguin, N. Candia, A. Ibacache, I. Medina-Yañez, G. Olivares, M. Ramirez, F. Vega-Macaya, A. Couve, J. Sierralta (Santiago, Chile)

    Objective: To identify genetic modifiers of decreased locomotion and neuromuscular junction defects associated with atlastin knockdown in motor neurons. Background: Hereditary spastic paraplegias (HSPs) are…
  • 2023 International Congress

    Are GDNF receptors the gatekeepers of GDNF efficacy during progressive nigrostriatal neuron loss?

    M. Salvatore, E. Kasanga, Y. Han, R. Mcmanus, W. Navarrete, V. Nejtek, J. Richardson (Fort Worth, USA)

    Objective: To determine if GDNF receptor expression levels in the striatum or substantia nigra (SN) change in relation to differences in tyrosine hydroxylase (TH) and…
  • « Previous Page
  • 1
  • …
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley